Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

OBP-2A Inhibitors

OBP-2A inhibitors represent a class of chemical compounds that target and inhibit the activity of the enzyme Odorant-Binding Protein 2A (OBP-2A). OBP-2A is a member of the larger family of odorant-binding proteins, which are involved in the detection and transport of small volatile molecules, particularly odorants, in the olfactory system of vertebrates and insects. Structurally, OBP-2A is characterized by a beta-barrel fold, which forms a hydrophobic binding pocket capable of interacting with various hydrophobic ligands, including volatile compounds. Inhibitors of OBP-2A are designed to bind within this pocket, effectively blocking the interaction between OBP-2A and its natural ligands. This inhibition can lead to a reduced ability to capture and transport odorant molecules, affecting the downstream signaling events in olfactory pathways.

The design of OBP-2A inhibitors often revolves around mimicking the structure of the natural ligands, utilizing small hydrophobic molecules that can fit into the binding pocket with high affinity. The interaction of these inhibitors with OBP-2A is governed by non-covalent forces such as van der Waals interactions, hydrogen bonding, and hydrophobic effects. Researchers studying OBP-2A inhibitors typically investigate the binding kinetics and the structural compatibility of these molecules through techniques such as X-ray crystallography and molecular docking studies. The precise tuning of these interactions is critical to achieving selective inhibition, minimizing off-target effects, and gaining insight into the fundamental roles OBP-2A plays in molecular recognition and signaling pathways. The inhibition of such proteins provides a window into understanding molecular mechanisms underlying olfactory processing, which is crucial for elucidating broader biological systems.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$110.00
$250.00
$936.00
$50.00
33
(2)

May modulate various signaling pathways, potentially affecting OBP-2A transcription.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Could inhibit protein synthesis, impacting OBP-2A protein levels.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

May inhibit RNA synthesis, affecting OBP-2A mRNA levels.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Could affect mTOR signaling, potentially influencing OBP-2A protein synthesis.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Might inhibit tyrosine kinases, potentially affecting signaling pathways influencing OBP-2A expression.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

Could influence MAPK signaling, affecting OBP-2A expression.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Might affect JNK signaling, potentially influencing OBP-2A expression pathways.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Could inhibit PI3K, potentially affecting OBP-2A expression.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$91.00
$139.00
$374.00
36
(1)

Might affect glucocorticoid-responsive elements, potentially influencing OBP-2A.

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
$138.00
$380.00
101
(4)

Could cause DNA damage, potentially affecting OBP-2A transcription.